CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study Evaluating the Safety and Efficacy of MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment in Patients With Advanced Soft Tissue Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06277154
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:33.945780+00:00
Published At: 2025-07-24T00:00:00+00:00
Record Updated At: 2025-07-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leiomyosarcoma", "Liposarcoma", "Synovial Sarcoma", "Angiosarcoma", "Undifferentiated Pleomorphic Sarcoma", "Epithelioid Sarcoma", "Malignant Peripheral Nerve Sheath Tumors", "Fibrosarcoma", "Pleomorphic Rhabdomyosarcoma", "Endometrial Stromal Sarcoma", "Desmoplastic Small Round Cell Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-24"
protocolSection.identificationModule.nctId: "NCT06277154"
protocolSection.identificationModule.officialTitle: "A Phase II Study Evaluating the Safety and Efficacy of MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment in Patients With Advanced Soft Tissue Sarcoma"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.